Novavax announces collaboration with SK bioscience for COVID-19 vaccine
SK bioscience will manufacture the vaccine antigen component for use in the final drug product globally during the pandemic period
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Argentina and Mexico to make AstraZeneca COVID-19 vaccine for Latin America
The deal between AstraZeneca and mAbxience of the INSUD Group includes technology to initially produce 150 million doses of the…
SeQuent Scientific to sell stake in Strides Pharma
Arun Kumar’s Family Office, part of the existing promoters of SeQuent Scientific to purchase 3.31 million shares for Rs 1,573…
Advent Life Sciences announces sale of KaNDy Therapeutics to Bayer
The sale is for $425 million upfront plus potential milestone payments of up to $425 million followed by further potential…
US signs $1.5 bn deal with Moderna for 100 mn doses of COVID-19 vaccine
Moderna’s deal with the US only pays out in full if the company hits certain unspecific timing benchmarks for vaccine delivery
Healthcare industry reports 95 deals worth $4.9 billion in July 2020
Deal value decreased by 40 per cent in July 2020, compared to June 2020, informs a report from GlobalData
AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine
As per the deal, AstraZeneca will deliver the first 100 million doses this year and 200 million doses by the end of 2021
Lupin signs exclusive distribution deal with ForDoz Pharma for complex injectable assets
The two assets, which are in the oncology and anti-infective therapeutic areas, are under development in the US and its…
Novavax signs deal with Serum Institute of India for COVID-19 vaccine supply
Serum Institute of India will have exclusive rights for the vaccine in India during the term of the deal
J&J signs pact with US for 100 million doses of COVID-19 vaccine
The US government is committing over $1 billion for this agreement
Canada signs deals with Pfizer, Moderna for supply of COVID-19 vaccines
Moderna to provide its mRNA-1273 vaccine candidate while Pfizer- BioNTech to supply their BNT162 mRNA-based vaccine candidate
Wockhardt signs partnership with UK Government to fill-finish COVID-19 vaccine
The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales
Sanofi, GSK to supply 100 mn doses of COVID-19 vaccine to US, in talks with EU for 300 mn doses
The deal is worth $2.1 billion and involves the supply of vaccines for 50 million people, with the option to buy another 500…
Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake
Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics
Advent International to acquire controlling stake in RA Chem Pharma from Micro Labs
The transaction is Advent’s sixth investment in the healthcare sector and seventh investment in India over the past twelve months
UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine
The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous…
Piramal Pharma Solutions to provide Bolt Biotherapeutics with immune-stimulating antibody conjugates…
Bolt’s Boltbody Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, is currently in a first-in-human Phase 1/2 clinical study…
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada)
The cost of acquisition is about $8.2 million
Canada subsidiary of Natco Pharma in settlement agreement with Celgene for onco drug
The terms of the agreement are confidential as per the agreement
Caplin Steriles signs distribution agreement with Xellia Pharmaceuticals
The former to license five of its injectable ANDAs to Xellia Pharmaceuticals for commercialisation in the US